Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. McCafferty (Belfast (Belfast), United Kingdom), K. Moffitt (Belfast (Belfast), United Kingdom), T. Ferguson (Belfast (Belfast), United Kingdom). Development of the first protease multiplex immunoassay for active neutrophilic serine protease biomarkers. 1143

Member's Comments

No comment yet.

Related content which might interest you: Increased detection of interleukin-;5 in sputum by addition of protease inhibitors Source: Eur Respir J 2001; 18: 685-691 Year: 2001 Development of a novel immunoassay for the measurement of active plasmin in patients with IPF Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017 The development of a novel immunoassay for the quantification of active tryptase Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017 Validation of an activity-based immunoassay for measurement of active cathepsin g in sputum Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020 LSC Abstract – A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition Source: Eur Respir J 2011; 37: 1083-1090 Year: 2011 Impact of SARS-CoV-2 heat inactivation on active protease biomarkers in sputum sol Source: Virtual Congress 2021 – Back to infection basics Year: 2021 A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection Source: Lung Science Conference 2015 Year: 2015 Evaluating a CD63 assay as a biomarker for SYK inhibitor activity Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 Development of secretory leukocyte protease inhibitor (SLPI) variants resistant to degradation by neutrophil elastase Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Secretory leukocyte proteinase inhibitor in lung cancer: an immunohistochemical and serological study Source: Eur Respir J 2006; 28: Suppl. 50, 388s Year: 2006 Human airway trypsin-like protease stimulates protease activated receptors and interactions of these receptors Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Plasma level of Mannose-binding lectin-associated serine protease (MASP-2) concentration in children with asthma. Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021 New enzyme linked immunosorbent assay using recombinant antigens from Saccharopolyspora rectivirgula for farmer‘s lung disease serodiagnosis Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012 Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation Source: Eur Respir J 2004; 23: 620-628 Year: 2004 Systemic upregulation of neutrophil α-defensins and serine proteases in neutrophilic asthma Source: Annual Congress 2011 - Molecular pathology and functional genomics of lung disease Year: 2011 Alpha-1 antitrypsin genotypes and associated inhibitory activity towards neutrophil serine proteinases, in vivo Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Expression of cysteine proteases in sarcoidosis and tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001 In vitro and in vivo characterisation of the novel neutrophil elastase inhibitor BI 1323495 Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020